Overview

Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)

Status:
Completed
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
Patients with chronic liver disease are at high risk of developing liver scarring (fibrosis), with ultimate risks of cirrhosis and liver cancer that may require liver transplant. The investigators would like to develop non invasive advanced Magnetic Resonance Imaging (MRI) techniques (MR diffusion, perfusion and elastography) to assess the degree of liver damage in patients with chronic liver disease. These techniques combined could reach high diagnostic performance for detection of liver fibrosis; and could decrease the number of liver biopsies, which have risks and sample only a small portion of the liver.
Phase:
Phase 4
Details
Lead Sponsor:
Bachir Taouli
Treatments:
Liver Extracts